postoperative nausea and vomiting
Conditions
Interventions
Group A (control group):5mg dexamethasone was injected intravenously during anesthesia induction
Group B (intravenous granisetron group):5mg dexamethasone intravenously during induction of anesthesia and 2mg granisetron intravenously at the end of surgery
Group C (point injection with granisetron group):5mg dexamethasone was injected intravenically during anesthesia induction, and 2mg granisetron was injected into Neiguan point at the end of surgery
Group D (point injection with 0.9% normal saline group):5mg dexamethasone was injected intravenically during anesthesia induction, and 2ml 0.9% normal saline was injected into Neiguan point at the end
Group E (acupressure group):5mg dexamethasone was injected intravenically during anesthesia induction. At the end of the operation, the patient was given acupressure at Neiguan point with an elastic w
Sponsors
West China Second Hospital, Sichuan University
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Women; Age range from 18 to 50 years old; ASAI-II level; Laparoscopic surgery; Unconscious and language communication barriers
Exclusion criteria
Exclusion criteria: Patients who refuse to participate in the study; Severe cardiorespiratory, hepatic, renal, neurological or endocrinal disease; Diabetes; Obesity; Allergies to Granisetron and Dexamethasone drugs; Patients who had taken H2 antagonists, antiemetic or psychoactive medication, nausea, retching or vomiting within 48 hours before surgery; Pregnant women; Lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ausea level;Vomiting episode; | — |
Countries
China
Contacts
Public ContactTian Wanli
Department of Anesthesiology Nursing, West China Second University Hospital
Outcome results
None listed